Patents by Inventor Jenna L. Cash

Jenna L. Cash has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150320826
    Abstract: This invention provides the use of one or more peptides derived from the C-terminal end of a Chemerin protein, or analogs or derivatives thereof for treatment of inflammation and/or endotoxic shock and/or treatment of wounds and/or reduction of levels of inflammatory chemokines in a subject, and one or more peptides derived from the C-terminal end of a Chemerin protein, or analogs or derivatives thereof for use in the treatment of inflammation and/or endotoxic shock, and/or wounds, or for the reduction of levels of inflammatory mediators.
    Type: Application
    Filed: December 5, 2014
    Publication date: November 12, 2015
    Inventors: David R. Greaves, Andreas Russ, Jenna L. Cash
  • Patent number: 8906865
    Abstract: This invention provides the use of one or more peptides derived from the C-terminal end of a Chemerin protein, or analogs, or derivatives thereof for treatment of inflammation and/or endotoxic shock and/or treatment of wounds and/or reduction of levels of inflammatory chemokines in a subject, and one or more peptides derived from the C-terminal end of a Chemerin protein, or analogs or derivatives thereof for use in the treatment of inflammation and/or endotoxic shock, and/or wounds, or for the reduction or levels of inflammatory mediators.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: December 9, 2014
    Assignee: ISIS Innovation Limited
    Inventors: David R. Greaves, Andreas Russ, Jenna L. Cash
  • Publication number: 20100150990
    Abstract: This invention provides the use of one or more peptides derived from the C-terminal end of a Chemerin protein, or analogs or derivatives thereof for treatment of inflammation and/or endotoxic shock and/or treatment of wounds and/or reduction of levels of inflammatory chemokines in a subject, and one or more peptides derived from the C-terminal end of a Chemerin protein, or analogs or derivatives thereof for use in the treatment of inflammation and/or endotoxic shock, and/or wounds, or for the reduction of levels of inflammatory mediators.
    Type: Application
    Filed: March 25, 2008
    Publication date: June 17, 2010
    Inventors: David R. Greaves, Andreas Russ, Jenna L. Cash